KRAS and familial pancreatic carcinoma: A comprehensive genomic analysis involving 24 pancreatic cancer patients revealed an average of 63 genetic alterations, per patient, predominantly comprising point mutations across various cellular pathways mutations in the Ras oncogene particularly oncogenic KRAS, represent the most prevalent oncogenic alterations observed in human cancers.